Junichi Tomomatsu

6PUBLICATIONS
20CO-AUTHORS
Gene and molecular therapyRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 15, 2025
The first case of GOLGA5-RET fusion-positive malignant spindle cell sarcoma of the head and neck responsive to selpercatinib.

Takehiro Nakao, Naoki Fukuda, Xiaofei Wang

|Jan 31, 2024
Clinical impact of proteinuria on renal function and treatment outcomes in patients with radioiodine-refractory thyroid cancer treated with lenvatinib.

Naoki Fukuda, Kazuhisa Toda, Hirotaka Suto

|Nov 19, 2021
Clinical Impact of Cachexia in Head and Neck Cancer Patients Who Received Chemoradiotherapy.

Naomi Hayashi, Yasuyoshi Sato, Yu Fujiwara

|Mar 09, 2021
Safety and pharmacokinetics of milademetan, a MDM2 inhibitor, in Japanese patients with solid tumors: A phase I study.

Shunji Takahashi, Yutaka Fujiwara, Kenji Nakano

|Jun 26, 2020
Efficacy of Nivolumab for Head and Neck Cancer Patients with Primary Sites and Histological Subtypes Excluded from the CheckMate-141 Trial.

Yasuyoshi Sato, Naoki Fukuda, Xiaofei Wang

|Jun 23, 2019
Phase I study of ipatasertib as a single agent and in combination with abiraterone plus prednisolone in Japanese patients with advanced solid tumors.

Toshihiko Doi, Yutaka Fujiwara, Nobuaki Matsubara

Pageof 1

Frequent Collaborators

4 joint publications

Xiaofei Wang

3 joint publications

Shunji Takahashi

3 joint publications

Yasuyoshi Sato

3 joint publications

Yukiko Sato